Theresa Heah, M.D., MBA, co-founder, vice-chair, and CEO of Eyexora, speaks with host Carey Powers at this year’s Ophthalmology Innovation Summit about her company’s fresh approach to building an ophthalmology company that centralizes R&amp;D, clinical, regulatory, and commercial expertise into a “one-stop shop.” Heah delves into the advantages of the hub and spoke model and how it will help overcome the gaps in the eye care landscape, as well as their plans to expand to the UK.  In this episode of the OIS podcast, learn about:  · Eyexora’s mission as a unique hub and spoke company dedicated to accelerating clinical innovation ·  The barriers in the ophthalmology field and how Eyexora’s approach will help overcome them ·  The advantages of building relationships on a global scale ·  Milestones and scientific areas to look out for in 2026  RESOURCES:   Carey Powers: <a href='https://ois.net/carey-powers/'>https://ois.net/carey-powers/</a>  Theresa Heah: <a href='https://www.linkedin.com/in/theresaheah'>https://www.linkedin.com/in/theresaheah</a>  Eyexora: <a href='https://eyexora.com/'>https://eyexora.com/</a>

<description>&lt;p&gt;Theresa Heah, M.D., MBA, co-founder, vice-chair, and CEO of Eyexora, speaks with host Carey Powers at this year’s Ophthalmology Innovation Summit about her company’s fresh approach to building an ophthalmology company that centralizes R&amp;amp;D, clinical, regulatory, and commercial expertise into a “one-stop shop.” Heah delves into the advantages of the hub and spoke model and how it will help overcome the gaps in the eye care landscape, as well as their plans to expand to the UK. &lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;In this episode of the OIS podcast, learn about:  &lt;/p&gt;&lt;p&gt;· Eyexora’s mission as a unique hub and spoke company dedicated to accelerating clinical innovation &lt;/p&gt;&lt;p&gt;·  The barriers in the ophthalmology field and how Eyexora’s approach will help overcome them &lt;/p&gt;&lt;p&gt;·  The advantages of building relationships on a global scale &lt;/p&gt;&lt;p&gt;·  Milestones and scientific areas to look out for in 2026 &lt;br/&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;b&gt;RESOURCES: &lt;/b&gt; &lt;br/&gt;&lt;br/&gt;Carey Powers: &lt;a href='https://ois.net/carey-powers/'&gt;https://ois.net/carey-powers/&lt;/a&gt;  &lt;/p&gt;&lt;p&gt;Theresa Heah: &lt;a href='https://www.linkedin.com/in/theresaheah'&gt;https://www.linkedin.com/in/theresaheah&lt;/a&gt;  &lt;/p&gt;&lt;p&gt;Eyexora: &lt;a href='https://eyexora.com/'&gt;https://eyexora.com/&lt;/a&gt; &lt;/p&gt;</description>

Theresa Heah, M.D., MBA, co-founder, vice-chair, and CEO of Eyexora, speaks with host Carey Powers at this year’s Ophthalmology Innovation Summit about her company’s fresh approach to building an ophthalmology company that centralizes R&amp;D, clinical, regulatory, and commercial expertise into a “one-stop shop.” Heah delves into the advantages of the hub and spoke model and how it will help overcome the gaps in the eye care landscape, as well as their plans to expand to the UK.    In th...

A Unique Approach to Tackling the Obstacles of Ophthalmology

Grace Ambrose-Zaken, Ph.D., president and CEO of Safe Toddles, speaks with host Robert Rothman about her mission to create a safer, easier-to-navigate world for children—perhaps one of the most underserved patients in eye care. Dr. Ambrose-Zaken discusses her breakthrough invention, the Pediatric Belt Cane, and how it transformed early mobility for blind children.  In this episode of the OIS podcast, learn about:  <ul><li>Why we need to have empathy and understanding for the visually impaired, especially children </li><li>The advantages of the belt cane over the white cane </li><li>The impediments of getting the belt cane to patients </li><li>How to support the visually impaired and Safe Toddles’ mission </li></ul>

<description>&lt;p&gt;Grace Ambrose-Zaken, Ph.D., president and CEO of Safe Toddles, speaks with host Robert Rothman about her mission to create a safer, easier-to-navigate world for children—perhaps one of the most underserved patients in eye care. Dr. Ambrose-Zaken discusses her breakthrough invention, the Pediatric Belt Cane, and how it transformed early mobility for blind children. &lt;/p&gt;&lt;p&gt; &lt;/p&gt;&lt;p&gt;In this episode of the OIS podcast, learn about:  &lt;/p&gt;&lt;ul&gt;&lt;li&gt;Why we need to have empathy and understanding for the visually impaired, especially children &lt;/li&gt;&lt;li&gt;The advantages of the belt cane over the white cane &lt;/li&gt;&lt;li&gt;The impediments of getting the belt cane to patients &lt;/li&gt;&lt;li&gt;How to support the visually impaired and Safe Toddles’ mission &lt;/li&gt;&lt;/ul&gt;</description>

Grace Ambrose-Zaken, Ph.D., president and CEO of Safe Toddles, speaks with host Robert Rothman about her mission to create a safer, easier-to-navigate world for children—perhaps one of the most underserved patients in eye care. Dr. Ambrose-Zaken discusses her breakthrough invention, the Pediatric Belt Cane, and how it transformed early mobility for blind children.    In this episode of the OIS podcast, learn about:   Why we need to have empathy and understanding for the visuall...

Creating an Easier-to-Navigate World for Children

What are the key qualities to being effective teammates? David Esposito, President and CEO of ONL Therapeutics, and Connie Chang, Chief Operating Officer of ONL Therapeutics, chat with host James Murray on the importance and value of transparency, trustworthiness, vulnerability, and candor amongst leadership to establish a strong company foundation. In this episode of the OIS podcast, learn about:<ul><li>Handling the little problems before they become big problems</li><li>The ability to execute big ideas effectively and efficiently</li><li>Building trust between companies, investors, and all other parties</li><li>Navigating the challenges of scaling</li></ul>

<description>&lt;p&gt;What are the key qualities to being effective teammates? David Esposito, President and CEO of ONL Therapeutics, and Connie Chang, Chief Operating Officer of ONL Therapeutics, chat with host James Murray on the importance and value of transparency, trustworthiness, vulnerability, and candor amongst leadership to establish a strong company foundation.&lt;br/&gt;In this episode of the OIS podcast, learn about:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Handling the little problems before they become big problems&lt;/li&gt;&lt;li&gt;The ability to execute big ideas effectively and efficiently&lt;/li&gt;&lt;li&gt;Building trust between companies, investors, and all other parties&lt;/li&gt;&lt;li&gt;Navigating the challenges of scaling&lt;/li&gt;&lt;/ul&gt;</description>

What are the key qualities to being effective teammates? David Esposito, President and CEO of ONL Therapeutics, and Connie Chang, Chief Operating Officer of ONL Therapeutics, chat with host James Murray on the importance and value of transparency, trustworthiness, vulnerability, and candor amongst leadership to establish a strong company foundation. In this episode of the OIS podcast, learn about: Handling the little problems before they become big problemsThe ability to execute big ideas eff...

Rolling Up Sleeves with David Esposito and Connie Chang

At this year’s Retina Innovation Summit, industry experts and leaders gathered in a two-part discussion on investment trends, regulatory environment and FDA changes, emerging therapies in ophthalmology, and more. Panelists include: Laura Feinleib, Managing Director at Redmile Group; Derrick Li, Chief Strategy Officer at ODC Life Sciences; Cameron Taylor, Managing Director at BofA Securities | Life Sciences; Wayne Caulder, Vice President &amp; General Manager of Surgical (U.S. &amp; Canada) at Bausch + Lomb; Paul Hallen, Vice President &amp; Distinguished Fellow at Alcon; Nida Sen, MD, VP, Ophthalmology Strategy &amp; Development Head at Sanofi; and Julian Smith, General Manager Portfolio Commercial Strategy - Eye Care at AbbVie. In this panel learn about: 🔹Investment trends in public and private markets 🔹Regenerative therapies, such as gene therapy and cell therapy 🔹The impact of patient and therapy adoption challenges—and how to navigate them 🔹Advice for entrepreneurs and start-ups on the best key strategies on driving partnership interest and networking

<description>&lt;p&gt;At this year’s Retina Innovation Summit, industry experts and leaders gathered in a two-part discussion on investment trends, regulatory environment and FDA changes, emerging therapies in ophthalmology, and more. Panelists include: Laura Feinleib, Managing Director at Redmile Group; Derrick Li, Chief Strategy Officer at ODC Life Sciences; Cameron Taylor, Managing Director at BofA Securities | Life Sciences; Wayne Caulder, Vice President &amp;amp; General Manager of Surgical (U.S. &amp;amp; Canada) at Bausch + Lomb; Paul Hallen, Vice President &amp;amp; Distinguished Fellow at Alcon; Nida Sen, MD, VP, Ophthalmology Strategy &amp;amp; Development Head at Sanofi; and Julian Smith, General Manager Portfolio Commercial Strategy - Eye Care at AbbVie.&lt;br/&gt;&lt;br/&gt;In this panel learn about:&lt;br/&gt;🔹Investment trends in public and private markets&lt;br/&gt;🔹Regenerative therapies, such as gene therapy and cell therapy&lt;br/&gt;🔹The impact of patient and therapy adoption challenges—and how to navigate them&lt;br/&gt;🔹Advice for entrepreneurs and start-ups on the best key strategies on driving partnership interest and networking&lt;br/&gt;&lt;br/&gt;&lt;br/&gt;&lt;/p&gt;</description>

At this year’s Retina Innovation Summit, industry experts and leaders gathered in a two-part discussion on investment trends, regulatory environment and FDA changes, emerging therapies in ophthalmology, and more. Panelists include: Laura Feinleib, Managing Director at Redmile Group; Derrick Li, Chief Strategy Officer at ODC Life Sciences; Cameron Taylor, Managing Director at BofA Securities | Life Sciences; Wayne Caulder, Vice President &amp; General Manager of Surgical (U.S. &amp; Canada) at...

The OIS Situation Room: Navigating healthcare in a shifting world order

Join Dr. Robert Rothman as he talks with Rajan Shukla about his journey from a family legacy in ophthalmology to pioneering new treatments for anterior segment diseases. Rajan shares how Vital Tears is making serum tears accessible nationwide and how Bright Star Therapeutics is developing innovative therapies like BrightMEM™ to transform ocular surface care. In this episode, learn about:<ul><li>The story behind Vital Tears and Bright Star Therapeutics</li><li>BrightMEM™ and its impact on treating limbal stem cell deficiency</li><li>The future of ocular surface and retinal therapies</li></ul>Hear how innovation is shaping the future of eye care.

<description>&lt;p&gt;Join Dr. Robert Rothman as he talks with Rajan Shukla about his journey from a family legacy in ophthalmology to pioneering new treatments for anterior segment diseases. Rajan shares how Vital Tears is making serum tears accessible nationwide and how Bright Star Therapeutics is developing innovative therapies like BrightMEM™ to transform ocular surface care.&lt;br/&gt;&lt;b&gt;In this episode, learn about:&lt;/b&gt;&lt;/p&gt;&lt;ul&gt;&lt;li&gt;The story behind Vital Tears and Bright Star Therapeutics&lt;/li&gt;&lt;li&gt;BrightMEM™ and its impact on treating limbal stem cell deficiency&lt;/li&gt;&lt;li&gt;The future of ocular surface and retinal therapies&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Hear how innovation is shaping the future of eye care.&lt;/p&gt;</description>

Join Dr. Robert Rothman as he talks with Rajan Shukla about his journey from a family legacy in ophthalmology to pioneering new treatments for anterior segment diseases. Rajan shares how Vital Tears is making serum tears accessible nationwide and how Bright Star Therapeutics is developing innovative therapies like BrightMEM™ to transform ocular surface care. In this episode, learn about: The story behind Vital Tears and Bright Star TherapeuticsBrightMEM™ and its impact on treating limbal stem...

Unlocking Breakthroughs in Ocular Surface Treatment

Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.

OIS Podcast | Ophthalmology's leading Podcast

Details

Recent Episodes